Virax Biolabs Group Limited Ordinary Shares Working Capital to Net Assets Ratio
Virax Biolabs Group Limited Ordinary Shares working capital to net assets ratio. Virax Biolabs Group Limited Ordinary Shares (VRAX) has a Working Capital to Net Assets ratio of 74.6% as of September 2025. Working capital of $3.78 Million (current assets of $4.15 Million minus current liabilities of $365.47K) is measured against net assets of $5.07 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible net worth ratio of Virax Biolabs Group Limited Ordinary Sha to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Virax Biolabs Group Limited Ordinary Shares (2020–2025)
Working capital to net assets ratio of Virax Biolabs Group Limited Ordinary Shares from 2020 to 2025. This chart shows how Virax Biolabs Group Limited Ordinary Shares's Working Capital to Net Assets ratio has evolved across 6 annual periods from 2020 to 2025. As of September 2025, the ratio stands at 74.6%, reflecting working capital of $3.78 Million against net assets of $5.07 Million USD. See Virax Biolabs Group Limited Ordinary Sha defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Virax Biolabs Group Limited Ordinary Shares Working Capital to Net Assets Ratio by Year (2020–2025)
Virax Biolabs Group Limited Ordinary Shares working capital to net assets ratio by year from 2020 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Virax Biolabs Group Limited Ordinary Shares from 2020 to 2025, covering 6 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see balance sheet size of Virax Biolabs Group Limited Ordinary Sha.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 77.3% | $4.22 Million | $5.46 Million | $4.89 Million | $673.21K | ▼ -4.7 pp |
| 2024 | 82.0% | $4.21 Million | $5.14 Million | $4.38 Million | $168.85K | ▼ -16.0 pp |
| 2023 | 98.0% | $8.73 Million | $8.90 Million | $9.63 Million | $908.40K | ▼ -2.0 pp |
| 2022 | 100.0% | $-1.20 Million | $-1.20 Million | $48.71K | $1.25 Million | ▼ -7.0 pp |
| 2021 | 107.0% | $-831.81K | $-777.32K | $39.62K | $871.43K | ▲ +7.0 pp |
| 2020 | 100.0% | $-1.22 Million | $-1.22 Million | $22.61K | $1.24 Million | — |